3hon MSN
H.C. Wainwright Reaffirms Buy on Harmony Biosciences Holdings, Inc. (HRMY) Despite Phase 3 Setback
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is among the best low-priced growth stocks to buy now. Analysts at H.C.
An update from MoonLake Immunotherapeutics ( ($MLTX) ) is now available. On September 28, 2025, MoonLake Immunotherapeutics announced the week 16 ...
Discover 3 top biotech stocks under $10 with lucrative options for covered call strategies. Click for these under-the-radar ...
Stockhead on MSN
Health Check: After raising up to $14m, Emvision is off and running with its Emu stroke detection push
Emvision has unveiled an equity raising of up to $14 million, to further commercialisation of its portable stroke detection ...
BitMine Immersion Technologies Inc. (NYSE: BMNR) is trading around $53 on Monday, up over 5% intraday, as the company ...
MLYS, SNDX, and TVTX are three promising biotech stocks that are poised for growth or potential buyouts. Here's what ...
Qure N.V. recently announced positive topline results from its pivotal Phase I/II trial of AMT-130, demonstrating statistically significant slowing of Huntington's disease progression, and entered ...
Always be cautious before investing in a penny stock. While some will turn out to be explosive winners, like Advanced Micro ...
Tylah Tully speaks with Neurizon Therapeutics (ASX:NUZ) managing director Dr Michael Thurn about the company’s latest funding success, regulatory milestones, and clinical development strategy.
Juventus will reveal their balance sheets for the 2024/2025 season during a meeting of the board later this week. It could ...
Immutep ( ($IMMP) ) just unveiled an announcement. On September 22, 2025, Immutep announced a research collaboration with the George Washington ...
IBM has recently partnered with HSBC on quantum computing. Here's why IBM stock is a better pick than pure-play quantum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results